In this post we can explore Thyrocare Technologies as a Multibagger in Warren Buffet way in Indian Stock Market.
Thyrocare is India’s first fully automated diagnostic laboratory with a focus on providing quality at affordable costs to laboratories and hospitals in India and other countries.
Thyrocare operates with a Centralized Processing Laboratory (CPL) in Mumbai – India for esoteric tests; and Regional Processing Laboratory in major metro cities of India and other parts of Asia. We have focus on strong technologies, strong brands and strong systems that enable all laboratories to give their clients the best of science and technology at an affordable cost.
Warren Buffet, Value & Growth Checklist
Following are the Checklist parameters:
Here are the positive factors regarding Thyrocare Technologies
- Company is having Steady EPS Growth
- Company have Low debts
- Corona Issue is Accelerating Growth of Company
Here are the concern factors regarding Thyrocare Technologies
- Valuation is High due to PE & PB
- Margin of Safety is Low – One has to Ensure Current Corona Impacts increases Sales
Based on the above analysis I would like to say that the Thyrocare Technologies possess Multibagger Stock properties and one can Invest in 2020. However one should not expect high compounded returns from this stock. It can be considered as Moderate Risk Moderate Returns investment.
Note If you are a new investor & would like to gain stocks like Next Page Industries then join our 3Y Multibagger Subscription & Reap Ultimate profits of 10X in 10Years. Don’t Wait – Subscribe!
Facebook Group | Ask your Queries here
Update: 30% less in net profits results